Organization
Vaximm
1 clinical trial
Clinical trial
An Open-label, Phase I/II Multicenter Clinical Trial of VXM01 in Combination With Avelumab in Patients With Progressive Glioblastoma Following Standard Treatment, With or Without Second SurgeryStatus: Active (not recruiting), Estimated PCD: 2021-12-31